Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document.

Published on Jul 1, 2010in Pancreas2.92
· DOI :10.1097/MPA.0B013E3181E4D9E5
Suresh T. Chari83
Estimated H-index: 83
(Mayo Clinic),
Guenter Kloeppel2
Estimated H-index: 2
(Mayo Clinic)
+ 3 AuthorsTooru Shimosegawa69
Estimated H-index: 69
(Mayo Clinic)
Sources
Abstract
Abstract Autoimmune pancreatitis (AIP) has been extensively reported from Japan, Europe, and the United States. Whereas the descriptions of AIP from Japan have predominantly been based on the presence of a distinct clinical phenotype, reports from Europe and the United States describe at least 2 histopathologic patterns in patients' condition currently diagnosed as AIP, viz, lymphoplasmacytic sclerosing pancreatitis (LPSP) and idiopathic duct centric pancreatitis (IDCP) or granulocyte epithelial lesion (GEL)-positive pancreatitis. Although the 2 entities share common histopathologic features (periductal lymphoplasmacytic infiltration and peculiar periductal fibrosis), expert pathologists can accurately distinguish them based on other unique histopathologic features. Clinically, the 2 entities have similar clinical presentation (obstructive jaundice/pancreatic mass and a dramatic response to steroids) but differ significantly in their demography, serological characteristics, other organ involvement, and disease relapse. While LPSP is associated with elevation in titers of nonspecific autoantibodies and serum IgG4 levels, IDCP does not have definitive serological autoimmune markers. All experts agreed that the clinical phenotypes associated with LPSP and IDCP should be nosologically distinguished; however, their terminology was debated. Whereas most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term "autoimmune" to describe IDCP.
📖 Papers frequently viewed together
28 Citations
20112.92Pancreas
14 Authors (Tooru Shimosegawa, ..., Lizhi Zhang)
896 Citations
2,772 Citations
References18
Newest
#1Phil A. Hart (The Ohio State University Wexner Medical Center)H-Index: 25
#2Yoh Zen (Kobe University)H-Index: 69
Last. Suresh T. Chari (Mayo Clinic)H-Index: 83
view all 3 authors...
Autoimmune pancreatitis (AIP) is distinct from calcifying and obstructive forms of chronic pancreatitis. Clinically and histologically it has two distinct subsets: (i) lymphoplasmacytic sclerosing pancreatitis or type 1 AIP which appears to be a systemic disease characterised by abundant infiltration of affected organs with immunoglobulin G4 (IgG4)-positive plasma cells and (2) duct-centric or type 2 AIP characterised by granulocyte epithelial lesions in the pancreas without systemic involvement...
411 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 60
#2Tooru Shimosegawa (Tohoku University)H-Index: 26
Last. Masao Omata (UTokyo: University of Tokyo)H-Index: 105
view all 19 authors...
Objective: To establish an appropriate steroid treatment regimen for autoimmune pancreatitis (AIP). Methods: A retrospective survey of AIP treatment was conducted in 17 centres in Japan. The main outcome measures were rate of remission and relapse. Results: Of 563 patients with AIP, 459 (82%) received steroid treatment. The remission rate of steroid-treated AIP was 98%, which was significantly higher than that of patients without steroid treatment (74%, 77/104; p Conclusions: The major indicatio...
698 CitationsSource
#1Makoto Otsuki (University of Occupational and Environmental Health Japan)H-Index: 33
#2Jae Bock ChungH-Index: 31
Last. Yasuyuki Kihara (University of Occupational and Environmental Health Japan)H-Index: 18
view all 15 authors...
In 2002, the Japan Pancreas Society (JPS) was the first in the world to propose diagnostic criteria for autoimmune pancreatitis (AIP). Since the concept of AIP has changed with the accumulation of AIP cases, the Research Committee of Intractable Pancreatic Diseases (RCIPD) provided by the Ministry of Health, Labour and Welfare of Japan and the JPS issued revised clinical diagnostic criteria of AIP in 2006. The Asan Medical Center of Korea also proposed diagnostic criteria for AIP in 2006. Howeve...
564 CitationsSource
#1Seunghyun Kwon (UOU: University of Ulsan)H-Index: 8
#2Myung-Hwan KimH-Index: 68
Last. Eugene K. ChoiH-Index: 16
view all 3 authors...
Abstract:Autoimmune chronic pancreatitis (AIP) is increasingly being recognized as a worldwide entity. In 2002, the Japan Pancreas Society published diagnostic criteria for AIP. Since then, increased attention toward this relatively new disease entity has enabled more cases of AIP to be correctly di
115 CitationsSource
#1Günter Klöppel (CAU: University of Kiel)H-Index: 87
Chronic pancreatitis is a fibroinflammatory disease of the pancreas. Etiologically, most cases are related to alcohol abuse and smoking. Recently, gene mutations have been identified as the cause of hereditary pancreatitis. Other chronic pancreatitis types that were defined in recent years are autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis) and paraduodenal pancreatitis (‘groove pancreatitis’, ‘cystic dystrophy of heterotopic pancreas’). This review describes and discusses th...
147 CitationsSource
#1Lizhi Zhang (Mayo Clinic)H-Index: 44
#1Lizhi Zhang (Mayo Clinic)H-Index: 7
Last. Thomas C. Smyrk (Mayo Clinic)H-Index: 98
view all 5 authors...
Autoimmune pancreatitis typically produces an enlarged pancreas with narrowing of the pancreatic duct, and can mimic carcinoma. Autoimmune pancreatitis usually responds to corticosteroid treatment, making it important to differentiate from pancreatic ductal adenocarcinoma. Affected patients often have an elevated serum IgG4. It has been proposed that increased numbers of IgG4-positive plasma cells in tissue might be a marker for the condition. We investigated the role of IgG4 staining in the dia...
345 CitationsSource
#1Vikram Deshpande (Harvard University)H-Index: 100
#2Sonia ChioccaH-Index: 1
Last. Gregory Y. LauwersH-Index: 85
view all 8 authors...
Autoimmune pancreatitis (AIP) is a mass forming inflammatory pancreatobiliary-centric disease. Recent reports of multiorgan inflammatory mass forming lesions with increased numbers of IgG4 positive plasma cells suggest that AIP may have a systemic component. In this study, we explore the systemic na
344 CitationsSource
#1Suresh T. Chari (Mayo Clinic)H-Index: 83
#2Thomas C. Smyrk (Mayo Clinic)H-Index: 98
Last. Michael B. Farnell (Mayo Clinic)H-Index: 71
view all 11 authors...
Background & Aims: The Japan Pancreas Society criteria for diagnosis of autoimmune pancreatitis (AIP) mandate presence of characteristic imaging (diffuse pancreatic enlargement with diffusely irregular, narrow pancreatic duct). AIP has unique histologic features associated with infiltration of tissues of affected organs with abundant IgG4-positive cells. We propose expanded diagnostic criteria for AIP with a cohort of histologically confirmed AIP. Methods: We reviewed the pancreatic imaging find...
1,118 CitationsSource
#1Kazuichi Okazaki (Kansai Medical University)H-Index: 68
#2Shigeyuki Kawa (Shinshu University)H-Index: 55
Last. Makoto Otsuki (University of Occupational and Environmental Health Japan)H-Index: 9
view all 18 authors...
In 1961, Sarles et al.1 asked the following question regarding the particular cases of pancreatitis with hypergammaglobulinemia: “Chronic inflammatory sclerosis of the pancreas—an autoimmune pancreatic disease?” As similar cases were rarely observed, a relationship between such pancreatitis and autoimmunity was viewed skeptically during the following several decades. In 1992, Toki et al.2 have reported 4 cases with unusual diffuse irregular narrowing of the main pancreatic duct and diffuse enlar...
676 CitationsSource
#1Giuseppe Zamboni (University of Verona)H-Index: 67
#2Jutta Lüttges (CAU: University of Kiel)H-Index: 45
Last. Günter Klöppel (CAU: University of Kiel)H-Index: 87
view all 9 authors...
Background and Aims Autoimmune pancreatitis seems to be a disease with a heterogeneous appearance. Our intention was to establish key diagnostic criteria, define grades of severity and activity, identify features of potential subtypes and evaluate the diagnostic relevance of biopsy specimens.
762 CitationsSource
Cited By241
Newest
Source
#1Mario Pelaez-Luna (UNAM: National Autonomous University of Mexico)H-Index: 17
Last. L.F. Uscanga-DomínguezH-Index: 5
view all 4 authors...
Source
#1Marco LanzillottaH-Index: 1
#1Marco Lanzillotta (UniSR: Vita-Salute San Raffaele University)H-Index: 14
Last. Jonas Rosendahl (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 9
view all 8 authors...
Introduction: Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centres, and largely depend on the experience of the physician. At this moment, the optimal regimen for inducing disease remission and preventing relapse is unknown. Objectives: The primary objective of this study is to describe current treatment regimens used in Europe, and to compare their effectiveness i...
2 CitationsSource
#1Luca Barresi (ISMETT)H-Index: 21
#2Matteo Tacelli (ISMETT)H-Index: 5
Last. EndoscopistsH-Index: 1
view all 29 authors...
BackgroundAutoimmune pancreatitis (AIP) is a rare, and relatively new, form of chronic pancreatitis. The management of AIP can vary considerably among different centres in daily clinical practice.O...
3 CitationsSource
#1Ashish Khandelwal (Mayo Clinic)H-Index: 11
#2Dai InoueH-Index: 20
Last. Naoki Takahashi (Mayo Clinic)H-Index: 51
view all 3 authors...
Objective Since the time of inception of autoimmune pancreatitis (AIP), our knowledge of autoimmune pancreatitis has expanded significantly. The aim of this review is to provide an update on clinical manifestations, diagnosis, imaging features, and treatment of AIP.
6 CitationsSource
#1Miroslav Vujasinovic (Karolinska University Hospital)H-Index: 11
#2Pia Maier (Karolinska University Hospital)H-Index: 1
Last. J-Matthias Löhr (KI: Karolinska Institutet)H-Index: 10
view all 11 authors...
BackgroundAutoimmune pancreatitis is a special form of chronic pancreatitis with strong lymphocytic infiltration and two histopathological distinct subtypes, a lymphoplasmacytic sclerosing pancreat...
1 CitationsSource
#1Akira Satou (Aichi Medical University)H-Index: 8
#2Kenji NotoharaH-Index: 37
Last. Yasuharu Sato (RMIT: RMIT University)H-Index: 31
view all 7 authors...
IgG4-related disease (RD) is a relatively new entity, which was first proposed in 2001. Since then, clinical and pathological characteristics of the disease have been investigated. As IgG4-RD has been studied extensively, the diagnostic criteria for IgG4-RD of each organ and the comprehensive diagnostic criteria for IgG4-RD have also been developed. However, one of the biggest challenges in the field is distinguishing between IgG4-RD and mimickers, which show overlapping features with IgG4-RD. I...
2 CitationsSource
#1Chaobin He (SYSU: Sun Yat-sen University)H-Index: 9
#2Dailin Rong (SYSU: Sun Yat-sen University)H-Index: 3
Last. Yanchun Lv (SYSU: Sun Yat-sen University)H-Index: 3
view all 9 authors...
Background To investigate whether the relative computed tomography (CT) value (rCT) of adjacent pancreatic parenchyma can distinguish focal‐type autoimmune pancreatitis (fAIP) from pancreatic ductal adenocarcinoma (PDAC).
1 CitationsSource